XML 54 R41.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Licenses, Asset Acquisitions and Contingent Consideration (Details) - Pulmokine, Inc. - License Agreement - In Process Research and Development Seralutinib - USD ($) |  | 1 Months Ended |  |  |
--- | --- | --- | --- | --- | ---
Oct. 02, 2017 | Oct. 31, 2017 | Jun. 30, 2024 | Jan. 31, 2024 | Jan. 31, 2021
Business Acquisition [Line Items] |  |  |  |  |
Product license term (in years) | 10 years |  |  |  |
Upfront payment |  | $ 5,500,000 |  |  |
Milestones accrued |  |  | $ 0 | $ 10,000,000 | $ 5,000,000
Maximum |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Development and regulatory milestone payments | $ 48,000,000 |  |  |  |
Development and regulatory milestone payments, due upon the initiation of a Phase 3 clinical trial | 5,000,000 |  |  |  |
Commercial milestone payments, payable | 45,000,000.0 |  |  |  |
Sales milestone payments, payable | $ 190,000,000.0 |  |  |  |

X
- Definition Business combination, contingent consideration, commercial milestone payments, payable. + References No definition available. + Details
Name: | goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable
Namespace Prefix: | goss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination Contingent Consideration Development And Regulatory Milestone Payments Due Upon The Initiation Of A Clinical Trial + References No definition available. + Details
Name: | goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsDueUponTheInitiationOfAClinicalTrial
Namespace Prefix: | goss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination Contingent Consideration Development And Regulatory Milestone Payments Payable + References No definition available. + Details
Name: | goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable
Namespace Prefix: | goss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business combination, contingent consideration, sales milestone payments, payable. + References No definition available. + Details
Name: | goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable
Namespace Prefix: | goss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Product license term. + References No definition available. + Details
Name: | goss_ProductLicenseTerm
Namespace Prefix: | goss_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront payment. + References No definition available. + Details
Name: | goss_UpfrontPayment
Namespace Prefix: | goss_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=goss_PulmokineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=goss_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentSeralutinibMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |